Rxsight, Inc. shares fall 1.52% after-hours following securities fraud lawsuit announcement.

Rxsight, Inc. declined 1.52% in after-hours trading, with the company facing a securities fraud class action lawsuit. The lawsuit alleges that the company failed to disclose adoption challenges and structural issues resulting in declines in sales. Additionally, the company announced the appointment of Raymond W. Cohen to its Board of Directors, which may not have been enough to offset the negative sentiment from the lawsuit.